by Lissa Harris
TECHNOLOGY	Kinase Screening Services Probe Signaling Pathways New service industry helps drug companies and academics measure the specificity of protein kinase inhibitors Email: Lissa Harris - lharris@the-scientist.com The Scientist 2005, 19(9):33 Published   9 May 2005

Kinases, the enzymes that catalyze phosphorylation events, have been implicated in hundreds of different diseases, including cancer, inflammatory diseases, and neurological disorders. Compounds that control their activity, therefore, hold rich promise for drug development.

(continued >>)

To continue reading this full article, you must be a subscriber to The Scientist.

You are only a few minutes away from unlimited access.

If you already have an online subscription, please Log-In Now.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.

Subscribe to The Scientist to get unlimited access to our premium content

Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95.  Subscribe now.

The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.